Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
193.76
+4.29 (2.26%)
At close: May 22, 2026, 4:00 PM EDT
193.50
-0.26 (-0.13%)
After-hours: May 22, 2026, 7:14 PM EDT
Biogen Analyst Ratings
Total Analysts
36
Consensus Rating
Buy
Price Target
$209.71
Upside
+8.23%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | May 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $214 → $225 | Buy | Reiterates | $214 → $225 | +16.12% | May 15, 2026 |
| Citigroup | Citigroup | Hold Maintains $190 → $200 | Hold | Maintains | $190 → $200 | +3.22% | May 1, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $200 → $206 | Hold | Maintains | $200 → $206 | +6.32% | Apr 30, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $213 → $222 | Buy | Maintains | $213 → $222 | +14.57% | Apr 30, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $246 → $260 | Strong Buy | Maintains | $246 → $260 | +34.19% | Apr 30, 2026 |
| Wedbush | Wedbush | Hold Maintains $191 → $196 | Hold | Maintains | $191 → $196 | +1.16% | Apr 30, 2026 |
| UBS | UBS | Hold → Strong Buy Upgrades $185 → $225 | Hold → Strong Buy | Upgrades | $185 → $225 | +16.12% | Apr 22, 2026 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $200 → $250 | Hold → Buy | Upgrades | $200 → $250 | +29.03% | Apr 20, 2026 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $177 → $214 | Hold → Buy | Upgrades | $177 → $214 | +10.45% | Apr 14, 2026 |
| Citigroup | Citigroup | Hold Maintains $215 → $190 | Hold | Maintains | $215 → $190 | -1.94% | Apr 13, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $193 → $189 | Hold | Maintains | $193 → $189 | -2.46% | Apr 13, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $190 → $200 | Hold | Maintains | $190 → $200 | +3.22% | Apr 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $228 → $237 | Strong Buy | Maintains | $228 → $237 | +22.32% | Apr 2, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $230 → $245 | Strong Buy | Maintains | $230 → $245 | +26.45% | Apr 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $250 → $275 | Buy | Maintains | $250 → $275 | +41.93% | Apr 1, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.